Eppin (SPINLW1; GeneID, 57119) is a single-copy gene encoding a cysteine-rich protein found only in the testis and epididymis, which contains both Kunitz-type and WAP-type four disulfide core protease inhibitor consensus sequences. This study demonstrates that, in seminal plasma and on human spermatozoa following ejaculation, Eppin is bound to semenogelin I (Sg). 
INTRODUCTION
Eppin (SPINLW1; GeneID: 57119) is a single-copy gene characterized by three splice variants encoding two isoforms [1] . These isoforms represent the first members of a family of protease inhibitors characterized by dual inhibitor consensus sequences on human chromosome 20q12-13.2 [1] . Eppin is a member of the WAP-type four-disulfide core (WFDC) gene family in its telomeric cluster. The Eppin protein is a cysteine-rich protein found only in the testis and epididymis, which contains both Kunitz-type and WAP-type four disulfide core protease inhibitor consensus sequences [1] . Western blots of extracts of human caput and corpus epididymal tissue and washed ejaculate spermatozoa demonstrate that Eppin occurs predominantly as a dimer (ϳ36-46 kDa); however, both monomer (18) (19) (20) (21) (22) (23) and multimer forms are present [1] . Immunohistochemical localization of Eppin revealed particularly strong staining in the ciliated cells of the epithelium of the ductuli efferentes as well as strong staining of spermatozoa within the lumen [1] .
Eppin is present on the surface of mouse spermatozoa both before and after capacitation [2] and, on the basis of protein expression data from Western blots and from immunohistochemical localization, a significant quantity of Eppin appears to be bound to the surface of human ejaculate spermatozoa [1] . During ejaculation, spermatozoa encounter a change in extracellular environmental conditions, particularly osmotic changes that require cell-volume adjustments when mixing with the secretions from the seminal vesicles and prostate. Bound surface molecules undergo a variety of modifications and/or removal and peripheral membrane proteins (decapacitation factors) are removed as spermatozoa begin capacitation in the female reproductive tract (see, e.g., [3, 4] ). Caudal epididymal spermatozoa are in an immotile state and, immediately following ejaculation in humans, sperm continue to appear immotile in the semen coagulum until liquefaction occurs and progressive motility begins [5] .
The role of semenogelin (Sg) during ejaculation has been reviewed by Robert and Gagnon [6] . Briefly, it is currently thought that Sg I and Sg II are initially protected from proteolysis by protein C inhibitor (PCI) in the seminal vesicles and that PSA (prostate-specific antigen, a serine protease) in the prostatic secretions is inactive, inhibited by high concentrations of zinc. PCI, a serine protease inhibitor, binds to both PSA and Sg II [7, 8] . During ejaculation, the mixing of Sg with prostatic secretions chelates most of the free zinc, which triggers release of PCI, aggregation of Sg and fibronectin, and activates PSA. PSA cleaves the coagulum proteins, resulting in the release of Sg proteolytic fragments. Extensive work by Gagnon's laboratory [9] [10] [11] [12] [13] [14] has demonstrated that Sg is bound to the sperm surface and that the sperm motility inhibitory factor in semen is the Nterminal (amino acids 69-160) of Sg I. Cleavage of Sg I by PSA during liquefaction removes Sg I from the sperm surface. Failure to remove Sg I from the sperm surface results in loss of motility [9] and inhibition of capacitation [15] .
The studies reported here, that Eppin and Sg I are bound together on human ejaculate spermatozoa, strengthen the concept that sperm-surface protein complexes are present on ejaculate spermatozoa for at least two functions: 1) pro-tection through antimicrobial activity and 2) survival and preparation of spermatozoa for fertility in the female reproductive tract. A recent report on the N-terminal of Sg [16] and our recent study of Eppin [17] demonstrate the complexes' antimicrobial properties. The importance of Eppin for the preparation of spermatozoa for fertility is evidenced by our report that antibody to Eppin in the male reproductive tract of immunized male monkeys, which disrupts Eppin's function, renders the males infertile [18] .
MATERIALS AND METHODS
All chemicals and reagents used in this study were molecular biology grade purchased from Sigma (St. Louis, MO). Purifications of plasmid and polymerase chain reaction (PCR) cDNAs were performed using the respective kits from Qiagen (Valencia, CA). Immobilon-P and N transfer membranes were purchased from Millipore (Bedford, MA). Human semen samples were obtained from Dr. S. Beyler, Department of Obstetrics and Gynecology, University of North Carolina Hospital, Chapel Hill, NC, and this study was approved by The Committee on the Protection of the Rights of Human Subjects at the University of North Carolina School of Medicine, Chapel Hill, NC.
Recombinant Protein Production
An Eppin cDNA (nucleotides 70-423) lacking part of the N-terminal secretory sequence was generated by PCR using the eppin-1/Bluescript clone [1] as template. This PCR was performed with Pfx Platinium Polymerase (Invitrogen, Carlsbad, CA) and cloned into pET-100D/TOPO (Invitrogen). In a similar manner, a human semenogelin cDNA (nucleotides 82-849) was generated by PCR using a human seminal vesicle cDNA library as template (a gift from Dr. Frank R. French, University of North Carolina, Chapel Hill, NC) and cloned into pET-100D/TOPO.
To produce N-and C-terminal fragments of Eppin, PCR products were generated using an LA Taq Kit (Takara Bio, Shiga, Japan) with appropriate restriction enzyme sites added to the primers to allow directional cloning into pFLAG-MAC (Sigma). The N-terminal Eppin cDNA construct (nucleotides 73-288) expresses amino acids 18-76 (Eppin ) and the Cterminal Eppin construct (nucleotides 283-423) expresses amino acids 75-133 (Eppin 75-133 ).
Two recombinant fragments of Sg (giͦ 2144902) N-terminal, Sg 24-163 (amino acids 24-163) and Sg 164-283 (amino acids 164-283), were produced from PCR products generated using an LA Taq Kit (Takara Bio) with appropriate restriction enzyme sites added to the primers to allow directional cloning into pFLAG-MAC (Sigma).
All constructs were verified by sequencing and expressed in DH5-␣. Bacterial lysates were purified on Ni-NTA agarose (pET-100D/TOPO) or anti-FLAG-M2 affinity gels (pFLAG-MAC).
Antiserum Production
Production of antisera to recombinant human Eppin (anti-rEppin) has been described [1] . Affinity-purified rabbit antisera to N-terminal amino acids 20-39 of mouse Eppin were made by Bethyl Laboratories (Montgomery, TX). Cysteine residue 33 was changed to an alanine. These antisera (anti-Q20E) react with both mouse and human Eppin. Affinity-purified rabbit antisera to a human semenogelin peptide (anti-S20H, aa 104-123) were made by Bethyl Laboratories (Montgomery, TX). Monoclonal antibodies to human semenogelin ( [19] ; MHS-5) were kindly provided by Dr. John Herr, University of Virginia.
Mass Spectrometry Identification of Eppin Binding Partners
Biotinylated human spermatozoa were immunoprecipitated with antiEppin antibodies and analyzed by SDS-PAGE. The resulting gel was stained overnight with 0.01% Bio-Rad R-250 Coomassie (Bio-Rad, Hercules, CA) in 10% acetic acid. Protein staining bands were excised, digested with trypsin, and analyzed by matrix assisted laser desorption/ionization (MALDI)/time of flight (TOF). MALDI TOF and MALDI TOF/ TOF were performed on an AB 4700 Voyager-Proteomics Discovery System (Applied Biosystems, Foster City, CA). The resulting peptide peaks were searched against the MSDB and NCBI databases using the MASCOT search engine. Mass spectrometry (MS) identification was done in the University of North Carolina-CH Proteomics Core.
Western Blot Analysis
Proteins were separated on reducing 10%-20% gradient gels (Bio-Rad) or, for Figure 1C , on reducing NuPAGE 4%-12% Bis-Tris gels (Invitrogen) and transblotted to Immobilon-P (Millipore) and either stained for protein with amido black or blocked with Tris buffered saline (TBS) (50 mM Tris pH 7.4, 150 mM NaCl) containing 3% BSA for 60 min at room temperature and probed with primary antibodies as described [1] . Two micrograms of recombinant protein were loaded per lane. Primary antibodies were used at a 1:2000 dilution and secondary antibodies (goat antirabbit IgG or goat anti-mouse IgG, 1:2000) were either alkaline phosphatase labeled and developed with nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate as substrate or peroxidase labeled and developed with chemiluminescence using Supersignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) according to the manufacturer's instructions.
For far-Western blots, proteins were immobilized on Immobilon-P, blocked as above, incubated 1-2 h or overnight (4ЊC) in protein probes, washed, and detected with primary and secondary antibodies as described above. The protein concentrations were determined using the Micro BCA Protein Detection Reagents (Pierce).
Labeling and Quantitative Binding Assay
Labeling of 20 g of rEppin or rSg with 125 I was carried out with the Iodo-gen direct method (Pierce) according to the manufacturer's instructions and the free 125 I removed with a micro Bio-spin 6 chromatography column (Bio-Rad). Proteins were immobilized on Immobilon-P, blocked as above, incubated for 1-4 h in either 125 I rEppin or 125 I rSg, and exposed for autoradiography overnight. The in vitro 125 I-rSg binding assay was a modification of that described previously [20] . In this assay, 4 g of rEppin were immobilized on a nitrocellulose membrane (0.45 m) using a Bio-Dot microfiltration apparatus (Bio-Rad) and the membrane washed with Tris buffered saline-Tween (TBST) (50 mM Tris pH 7.4, 150 mM NaCl with 0.05% Tween 20) and blocked with 5% BSA in TBST. Triplicate bio-dots on a membrane with or without Eppin (control) were incubated in increasing amounts of 125 I-rSg overnight at 4ЊC, washed in TBST, cut into 1-cm squares, each containing a single dot, and counted in a ␥ counter. To demonstrate competition for binding, increasing amounts of unlabeled rSg were added to the 125 I-rSg Eppin bio-dot incubation mixtures.
Immunoaffinity Chromatography
Affinity chromatography was carried out with a Seize-X immunoprecipitation kit (Pierce) using affinity-purified anti-Q20E antibodies or antirecombinant Eppin antibodies. Human spermatozoa were washed several times in Biggers-Whitten-Whittingham (BWW) medium by centrifugation at 500 ϫ g for 5 min and biotinylated with EZ-Link NHS-biotin (Pierce). Labeled sperm were washed three times in PBS, sonicated for 30 sec on ice, centrifuged (12 000 rpm, 10 min), and the supernatant applied to the anti-Eppin antibody Seize-X beads. Human seminal plasma, diluted 1:4 with Seize-X immunoprecipitation kit binding buffer (Pierce), was applied to the affinity-purified anti-Q20E antibody Seize-X beads. Columns were washed and eluted according to the manufacturer's instructions. Preimmune IgG from the immune rabbits served as the control for nonspecific binding to immunoaffinity beads with the same samples.
Immunofluorescence
Human spermatozoa were washed twice in BWW medium and once with PBS by centrifugation at 500 ϫ g for 5 min and resuspended in PBS. Spermatozoa were fixed in 3.7% formaldehyde in PBS, washed, blocked with normal goat serum, and resuspended in PBS. For indirect immunofluorescence, spermatozoa were probed with mouse monoclonal antiserum to recombinant human semenogelin ( [19] ; MHS-5) and affinity-purified anti-Eppin (Q20E) at 1:100 dilutions. Antibody binding was detected with Alexa Fluor-488-or Alexa Fluor-568-labeled goat anti-rabbit IgG (Molecular Probes, Eugene, OR) and Alexa Fluor-488-labeled goat anti-mouse IgG (Molecular Probes) at 1:5000 dilution. 
RESULTS
The presence of Eppin on the surface of human ejaculate spermatozoa can be demonstrated by Western blot analysis of biotinylated spermatozoa, immunoprecipitation, and by immunolocalization with anti-Eppin antibodies (Figs. 1 and  2) . Immunoprecipitation of Eppin from biotinylated spermatozoa resulted in the co-precipitation of a 27-kDa protein that has been subsequently identified by MALDI/TOF/MS after trypsin digestion of the protein. The tryptic peptides (Fig. 1D) were identified as human semenogelin I (Sg). The assignment of each peak in the spectrum to the peptides of this protein is shown in Figure 1D . The actual sequences obtained are shown in Table 1 . Analysis of the Sg sequences from the MS data indicates that the fragments bound to Eppin had a maximal apparent molecular weight of 27 kDa. The identification of Sg as a biotinylated sperm surface protein that coimmunoprecipitates with anti-rEppin antibodies (Fig. 1A, lanes 1 and 2) indicates that an Eppin-Sg complex exists on the sperm surface. The reverse experiment of immunoprecipitation of Sg from biotinylated spermatozoa with anti-S20H also demonstrated that an EppinSg complex exists on the sperm surface (data not shown). Western blots of biotinylated human spermatozoa demonstrate that Eppin in its monomer form (16-18 kDa; bracket, Fig. 1B, lane 3) and in its dimer form (33-36 kDa; arrow, Fig. 1B, lane 3) is biotinylated on the sperm surface (Fig.  1B, lane 2) . Moreover, the monomer form of Eppin on the sperm surface (16-18 kDa; bracket, Fig. 1B , lanes 2 and 3) binds semenogelin (Fig. 1B, lane 1) when probed with 125 I-rSg. 125 I-rSg does not appear to bind to the native Eppin dimer (33-36 kDa; Fig. 1B, lane 3) .
Immunoprecipitation of Eppin from human seminal plasma with affinity-purified antisera to Eppin amino acids 20-39 (anti-Q20E) results in the coprecipitation of Eppin in its monomer (1ϫ), dimer (2ϫ), 4ϫ, and 8ϫ forms (arrow and asterisks, Fig. 1C, lane 1) and semenogelin (Sg), visualized as a 27-kDa protein (asterisk, Fig. 1C, lane 2) that corresponds to that identified by MALDI/TOF/MS. Smaller peptide fragments of 18-22 kDa from Sg are also immunoprecipitated with Eppin (Fig. 1A, lane 2, and Fig. 1C, lane 2) .
Immediately following ejaculation in humans, sperm appear trapped in the semen coagulum as liquefaction and progressive motility begin [5] . As shown in Figure 2C , Ep- pin (red) and semenogelin (green) are both present within the coagulum and strongly colocalize in large aggregates (yellow, Fig. 2C ). At higher magnification (Fig. 2D) , semenogelin-coated sperm heads (green, arrow) are clearly bound to a patchwork of Eppin-Sg complexes within the coagulum. On individual spermatozoa within the mass of the coagulum, Eppin and semenogelin are often seen to colocalize (arrow, yellow) on the head and particularly in the postacrosomal region (Fig. 2E) .
To study the binding of Eppin and semenogelin in more detail, in vitro experiments with recombinant Eppin (rEppin) and recombinant semenogelin (rSg) were carried out. As shown in Figure 3 , when rEppin and rSg are incubated together for 3 h and immunoprecipitated with antiEppin (anti-Q20E), rSg (arrow) can be detected in the immunoprecipitate with monoclonal MHS-5. Immunoprecipitation with anti-Sg similarly results in the detection of Eppin in the immunoprecipitate (data not shown).
Additionally, Eppin-semenogelin binding can be demonstrated by far-Western blotting. Figure 4A (lane 3) demonstrates the monomer (arrow) and multimer forms (*) of rEppin recognized by the anti-Q20E antiserum. When the blot is incubated in rSg, washed, and probed with anti-Sg (anti-S20H), all forms of rEppin bind rSg (lane 1). Antiserum to Sg (anti-S20H) does not recognize rEppin (lane 2). Control blots of an irrelevant recombinant protein (NASP) probed with rSg demonstrate that nonspecific binding to other His-tagged proteins does not occur (Fig. 4B , lane 5) and that anti-S20H does not recognize NASP or the His-tag (lane 6). Similarly, rSg on a blot binds rEppin by far-Western blot analysis (Fig. 4C) . The 35-kDa rSg and incomplete translation products (lane 1) are recognized by antisemenogelin (lane 2). When the blot is incubated in rEppin, washed, and probed with anti-Eppin (anti-Q20E), the rSg binds rEppin (lane 3). Anti-Eppin does not recognize Sg (lane 4).
Quantitative binding data (Fig. 5A ) demonstrate that increasing amounts of 125 I-rSg bind to 4 g of rEppin in a saturable manner and that increasing amounts of unlabeled rSg compete for binding sites (Fig. 5B) . The binding of 125 I-rSg to rEppin can be visualized on blots probed with 125 I-rSg. Figure 6A demonstrates that rEppin on a blot (lane 1) binds 125 I-rSg (lane 2) and that, when competed with 10ϫ unlabeled rSg, the binding is significantly reduced (lane 3). Conversely, rSg on a blot binds 125 I-rEppin (data not shown).
To address the specificity of Eppin-semenogelin binding, we expressed fragments of both proteins. The Eppin Nterminal fragment (Eppin 18-76 ) appears as a single proteinstained band with only weak multimer formation (Fig. 6B,  lane 1) while the Eppin C-terminal fragment (Eppin 75-133 ) appears as several protein-stained bands (Fig. 6B, lane 3 fragment (Fig. 6B, lanes 3 and 4) and not to the N-terminal, Eppin 18-76 fragment.
Incubation of 125 I-rEppin with the two recombinant fragments of the Sg N-terminal, Sg (Fig. 7, lane 1 ; amino acids 24-163) and Sg (Fig. 7, lane 3 ; amino acids 164-283) demonstrates that Eppin binding is restricted to Sg (Fig. 7, lanes 3 and 4) . The Sg 164-283 fragment contains the only cysteine residue (Cys 239 ) present in Sg. Therefore, we tested whether the reduction and carboxymethylation of Cys 239 would block the binding of 125 IrEppin. As shown in 
DISCUSSION
This study has demonstrated that Eppin is bound to Sg in seminal plasma and on human spermatozoa following ejaculation. Six different experimental approaches: 1) immunoprecipitation from spermatozoa and seminal plasma with anti-Eppin, 2) colocalization in semen and spermatozoa, 3) incubation of rEppin and rSg and immunoprecipitation with either anti-Eppin or anti-Sg, 4) far-Western blotting of Eppin and Sg, 5) saturation binding of 125 I-Sg to Eppin, which is competed by unlabeled Sg, and 6) direct binding of 125 I-Sg to Eppin on a blot, which is competed with unlabeled Sg, all demonstrate that Eppin and Sg bind to each other.
The physiological significance of the Eppin-Sg complex bound on the surface of ejaculate spermatozoa lies in its ability to provide antimicrobial activity for spermatozoa, which has been reported for both Eppin- [17] and semenogelin-derived peptides [16] and in its ability to provide for the survival and preparation of spermatozoa for fertility in the female reproductive tract [18] . Additionally Eppin may protect spermatozoa from proteolytic attack by allowing cleavage of Sg bound to Eppin but not of Eppin itself. Semenogelin that is coimmunoprecipitated with Eppin from spermatozoa and seminal plasma has an apparent molecular weight of Յ27 kDa, which is smaller than full-length Sg (52 kDa). Therefore, the recovered Sg fragments bound to Eppin (Fig. 1 ) have probably been cleaved by PSA (a serine protease with restricted chymotrypsin-like specificity) or similar protease in the ejaculate [9] . PSA cleaves Sg almost exclusively at tyrosine and leucine residues [21] , and there are two known cleavage sites (Leu-246 and Leu-261), either of which would provide an N-terminal semenogelin peptide fragment of approximately 27 kDa. Our finding that the Eppin binding site on Sg is within amino acids 164-283 would allow PSA to cleave Sg and the 27-kDa fragment would still remain attached to Eppin on the sperm surface. However, continued PSA activity would mostly likely remove Sg from its Eppin-binding site. Similarly, the sperm motility inhibitory factor in semen described by Gagnon's laboratory [9] (Sg amino acids 85-136 in [21] ; giͦ 2144902 amino acids 108-160) is located within the Sg fragment bound to Eppin. It too would most likely be removed with continued PSA activity because its presence can inhibit capacitation [15] .
As reported previously [1] , native Eppin occurs as multimers in both seminal plasma and in the epididymis. These are thought to form by the intermolecular interaction of the 14-cysteine residues. Mass spectroscopy studies on reduced and carboxymethylated recombinant forms of Eppin have determined that the actual mass of the dimer is 33 kDa and that it is unlikely that every cysteine is carboxymethylated (unpublished results). The present study demonstrates that, while multimer recombinant forms of Eppin can bind Sg (Fig. 4) , only the native monomers binds Sg in the overlay technique (Fig. 1) . Moreover, it is the Eppin 75-133 C-terminal fragment (Fig. 6 ) that binds Sg (Sg 164-283 , Fig. 7) , and this sequence contains the only cysteine in human Sg I (Cys-239), which is necessary for Eppin binding. If a disulfide linkage occurs between Sg and Eppin, it might allow several Sg molecules (or fragments) to bind Eppin, multiplying Eppin's effectiveness as a binding site. Quantitative determination of Sg binding to Eppin (Fig. 5) shows that the binding is saturable; however, a calculation of the number of binding sites is not realistic because the 4 g Eppin used in the microtiter wells was in a highly multimeric state of unknown molecular weight.
In conclusion, the Eppin-Sg complex found on human ejaculate spermatozoa is thought to be part of a larger network of protein complexes on the sperm surface that provides a protective shield before capacitation in the female reproductive tract. Such sperm-coating proteins function in innate immunity [17] , antimicrobial activity, and inhibition of proteases that may directly attack the sperm plasma membrane. Anti-Eppin antibodies may disrupt the EppinSg complex and inhibit the proper removal of Sg by PSA, forming the basis for the inhibition of fertility by anti-Eppin antibodies [18] . Colocalization of Eppin and Sg in the sperm-seminal plasma coagulum (Fig. 2 , C and D) allows one to visualize the unquestionable need for spermatozoa to escape this coagulum to become fertile and proceed along the female reproductive tract.
